Licensing opportunities and technologies are sourced from our own drug discovery and diagnostics labs and the UK’s Medical Research Council.

LifeArc is responsible for the technology transfer of patented and protected technologies from the MRC, LifeArc and other academic and charitable organisations.

Research Tools
NS0 cell line
Cell line

Key Contact
Mike Bond
Business Manager
+ 44 (0)20 7391 2727
Therapeutics
ECRA AHSV: A safer vaccine to tackle multiple serotypes of African Horse Sickness Virus
Animal health

Lic opps detail

  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email support@thewebkitchen.co.uk.
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
  • We would love to send you information about LifeArc news and events. Please let us know if you would like us to contact you by selecting one of the following options:

Therapeutics
ECRA BTV: A safer vaccine to tackle every strain of Bluetongue Virus
Animal health

Lic opps detail

  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email support@thewebkitchen.co.uk.
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
  • We would love to send you information about LifeArc news and events. Please let us know if you would like us to contact you by selecting one of the following options:

Therapeutics
MIF inhibitors for the treatment of inflammation
Inflammation

Key Contact
Derek Sheader
Business Development Manager
+ 44 (0) 143 854 4560
Therapeutics
GalR2 Agonists for the Treatment of Pain
Neuropathic Pain

Key Contact
Derek Sheader
Business Development Manager
+ 44 (0) 143 854 4560
Therapeutics
Beta amyloid-targeted therapeutic antibody
Alzheimer’s Disease

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565
Therapeutics
Anti-microbial agent with utility in tuberculosis
Anti-microbial

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565
Therapeutics
ALK ADC for the Treatment of Neuroblastoma
Cancer

Key Contact
Derek Sheader
Business Development Manager
+ 44 (0) 143 854 4560
Therapeutics
IL16 antibodies for inflammation
Inflammation

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565
Therapeutics
IL17BR antibodies for inflammation
Inflammation

Key Contact
Zhi Zhang
Business Development Manager
+ 44 (0)20 7391 4096
Therapeutics
Ang2 specific biotherapeutic
Biotherapeutic

Key Contact
Rachael Brooker
Business Manager
+ 44 (0)20 7391 7015
Therapeutics
Potent ULK1 inhibitors as novel cancer therapeutics
Cancer

Key Contact
Derek Sheader
Business Development Manager
+ 44 (0) 143 854 4560
Therapeutics
Matriptase, a small molecule inhibitor
Inflammation

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565
Therapeutics
PAICS small molecule inhibitors for cancer
Cancer

Key Contact
Kevin Buchan
Business Development Manager
+ 44 (0) 1438 544565